Quick Takeaways
- AWM Investment Company, Inc. filed SCHEDULE 13G for AYTU BIOPHARMA, INC Common Stock (ASPI).
- Disclosed ownership: 6.9%.
- Date of event: 30 Jun 2025.
AWM Investment Company, Inc. - 30 Jun 2025 SCHEDULE 13G Report for AYTU BIOPHARMA, INC Common Stock (ASPI)
- Filing Manager
- AWM Investment Company, Inc.
- Reporting Manager
- AWM Investment Company, Inc.
- Security
- AYTU BIOPHARMA, INC Common Stock
- Symbol
- ASPI
- Shares outstanding
- 8,983,681 shares
- Disclosed Ownership
- 619,874 shares
- Ownership
- 6.9%
- Form type
- SCHEDULE 13G
- Filing time
- 14 Aug 2025, 14:58:55 UTC
- Date of event
- 30 Jun 2025
- Next filing
- 13 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"AWM Investment Company, Inc. disclosed 6.9% ownership in AYTU BIOPHARMA, INC Common Stock (ASPI) on 30 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Aug 2025, 14:58.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| AWM Investment Company, Inc. | 6.9% | 619,874 | 619,874 | 0 | Adam Stettner | Executive Vice President |